Ignite Creation Date:
2024-05-06 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05063162
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2021-09-21
Brief Title:
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein MOG Antibody-associated Disease MOG-AD
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-05
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-21
First Submit QC Date:
September 21 2021
Study First Post Date:
2021-09-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL